Anticholinergics Flashcards
KT: anticholinergic bronchodilator
agent that blocks parasympathetic nervous fibers, which allow relaxation of smooth muscle in the airways
KT: antimuscarinic bronchodilator
same as anitcholinergic broncodilator—agent that blocks the effectof Ach at the cholinergic site
KT: cholinergic/muscarinic
agent that produces the effect of Ach
KT: parasympatholytic
blocking parasympathetic nervous fibers
KT: parasympathomimetic
producing effects similar to the parasympathetic nervous system
Clinical indications for use of an anticholinergic bronchodilator
COPD maintenance
acute exacerbation
Clinical indication for anticholinergic and β-agonist bronchodilators
COPD + airway obstruction
Atropine
Anticholinergic, Parasympatholytic, Antimuscarinic
Not recommended for inhalation
Ipatropium bromide
Anticholinergic, Parasympatholytic, Antimuscarinic
Atrovent HFA - HFA MDI, SVN, Nasal Spray
Onset: 15 min; Peak: 1-2 hr; Duration: 4-6 hr
Ipatropium bromide + Albuterol
Combination of a anticholinergic and β2-agonist
Combivent - MDI
Duoneb - SVN
Onset: 15 min; Peak: 1-2 hr; Duration 4-6 hr
Tiotropium bromide
Anticholinergic, Parasympatholytic, Antimuscarinic
Spiriva - DPI
Selective for M1 & M3 receptor types
Onset: 30 min; Peak: 1-3 hr; Duration: 24 hr
Glycopyrrolate
not something we really use
not approved for inhalation
used parenterally to reverse neuromuscular blockade
Aclidinium bromide
Anticholinergic, Parasympatholytic, Antimuscarinic
Tudorza Pressair -DPI
Currently being developed by Forest Laboratories
log-acting anticholinergic bronchodilator
Pharmacologic effects of anticholinergics
increased HR, pupil dilation, drying of airways, slows mucus production, inhibits constriction
M1 receptor
- parasympathetic ganglia
- facilitate neurotransmission and bronchoconstriction
- cause secretion and rhinitis in nose